- Is De-Crease Cancer a tax-exempt 501(c)(3)?
- Yes. De-Crease Cancer is recognised by the IRS as a 501(c)(3) organisation (EIN 82-2548600). The IRS recognised De-Crease Cancer as tax-exempt in September 2017.
- What is De-Crease Cancer's EIN?
- De-Crease Cancer's Employer Identification Number (EIN) is 82-2548600. The EIN was assigned by the IRS in September 2017. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does De-Crease Cancer do?
- The mission of De-Crease Cancer is to raise money for cancer research.
- Where is De-Crease Cancer located?
- De-Crease Cancer is located at 10 Darby Court, Manalapan, NJ, 07726.
- When was De-Crease Cancer founded or recognised by the IRS?
- De-Crease Cancer was recognised by the IRS as a tax-exempt organisation in September 2017. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is De-Crease Cancer's annual revenue?
- On its most recent Form 990 (fiscal year 2025), De-Crease Cancer reported $0 in total revenue and $1K in total expenses.
- Has De-Crease Cancer been auto-revoked by the IRS?
- No. De-Crease Cancer (EIN 82-2548600) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is De-Crease Cancer listed in IRS Publication 78?
- Yes. De-Crease Cancer is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
